Nasdaq - Delayed Quote USD

BlackRock Health Sciences Opportunities Portfolio (BHSRX)

58.84
+1.26
+(2.19%)
At close: 8:05:09 AM EDT

Top 10 Holdings (46.42% of Total Assets)

SymbolCompany% Assets
Eli Lilly and Company 8.03%
AbbVie Inc. 6.91%
Boston Scientific Corporation 5.43%
UnitedHealth Group Incorporated 5.25%
Abbott Laboratories 4.78%
Thermo Fisher Scientific Inc. 3.55%
Stryker Corporation 3.49%
Johnson & Johnson 3.01%
Amgen Inc. 2.99%
Gilead Sciences, Inc. 2.98%

Sector Weightings

SectorBHSRX
Healthcare   99.86%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Cash 1.60%
Stocks 98.00%
Bonds 0.01%
Others 0.40%
Preferred 0.00%
Convertible 0.00%

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

Equity Holdings

Average BHSRX Category Average
Price/Earnings 0.03 24.55
Price/Book 0.2 5.28
Price/Sales 0.49 2.06
Price/Cashflow 0.05 17.54
Median Market Cap 111,843.94 34,862.81
3 Year Earnings Growth 0.41 32.48

Bond Holdings

Performance & Risk

YTD Return -4.37%
5y Average Return 4.75%
Rank in Category (ytd) 29
% Rank in Category (ytd) --
Beta (5Y Monthly) 0.62
Morningstar Risk Rating

Fund Overview

Category Health
Fund Family BlackRock
Net Assets 6.91B
YTD Return 1.20%
Yield 0.02%
Morningstar Rating
Inception Date Oct 16, 2000

Fund Summary

The fund invests at least 80% of its total assets in equity securities, primarily common stock, of companies in health sciences and related industries. The health sciences sector can include companies in health care equipment and supplies, health care providers and services, biotechnology, and pharmaceuticals. It will concentrate its investments (i.e., invest more than 25% of its assets) in health sciences or related industries, and may invest in companies located in non-U.S. countries.

Related Tickers